Flutine 20

Quick links to important sections

Flutine 20

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flutine 20

Flutine 20 is a prescription-only medication classified as a Selective Serotonin Reuptake Inhibitor (SSRI), primarily used to support mental balance and regulate mood.


Quick Facts

Property Description
Active ingredient Fluoxetine hydrochloride (Fluoxetine)
Form Capsule (typically 20 mg strength)
Pharmacological class Selective Serotonin Reuptake Inhibitor (SSRI)
Common use Modulation of mood and emotional stability
Origin Synthetic compound

Identity, Composition, and Origin

Flutine 20 is a synthetic compound administered for oral administration as a standardized capsule. Its essential component is fluoxetine hydrochloride, which serves as the active drug, Fluoxetine. This precise formulation ensures consistent delivery of the single-ingredient product. The use of fluoxetine in this therapeutic context is broadly clinically recognized for its efficacy in managing emotional imbalances. The formulation of this specific brand focuses on the standard strength, making it one presentation among many carrying the fluoxetine compound.


Pharmacological Class and General Purpose

The medication is categorized as an Antidepressant agent and belongs specifically to the SSRI class, a type of psychoanaleptic agent used to influence mood regulation. As a selective serotonin reuptake inhibitor, fluoxetine is categorized within this specific class of drugs. The general purpose of this medication is to help stabilize emotional states that have become functionally impaired, utilizing monoamine neurotransmitter level modulation. This SSRI approach is often applied to assist adult patients in restoring a sense of psychological equilibrium, positioning it as a foundational treatment in the support of mood stability.

What side effects are possible with Flutine 20?

Possible Side Effects and Safety Information

The safety profile of Fluoxetine (Flutine 20) is officially defined by government regulatory documents, which classify adverse reactions by their likelihood of occurrence and the body system affected. This classification helps structure the documented risks associated with the medicine.

Adverse Reactions and Frequency

Adverse reactions classified as Very Common (may affect more than 1 in 10 people) typically involve the psychiatric, nervous, and gastrointestinal systems. These include insomnia, headache, diarrhea, nausea, and fatigue. Reactions categorized as Common (may affect up to 1 in 10 people) expand the profile to include anxiety, tremor, dry mouth, decreased appetite, rash, sweating, and sexual dysfunction such as decreased libido or ejaculation disorder.


Serious Safety Considerations

Official labeling highlights several serious safety concerns. A prominent warning addresses the risk of Suicidal Thoughts and Behavior, particularly in children, adolescents, and young adults (up to age 24). Other documented risks include the emergence of Serotonin Syndrome and the potential for Activation of Mania/Hypomania. The label also notes the risk of QT Prolongation (a heart rhythm change), Seizures, and the possibility of severe systemic reactions like Hyponatremia and Severe Allergic Reactions (e.g., Stevens-Johnson Syndrome).


Population and Contextual Notes

The safety profile includes specific statements for certain groups. The risk of suicidal thoughts is focused on the younger population, while older adults may have a higher risk of Hyponatremia. Furthermore, safety patterns tied to the timing of use include the potential for Akathisia (restlessness) in the initial weeks of treatment, and reports of sexual dysfunction persisting after discontinuation. Caution is advised regarding the use of Fluoxetine in patients with hepatic impairment.

Overdose and Emergency Response

Overdose and when to seek help

This information describes the officially documented manifestations and required emergency actions for Flutine 20 (Fluoxetine) overdose, as stated in government regulatory documents.


Documented Overdose Manifestations

Official regulatory sources note that overdose with fluoxetine alone may present with central nervous system effects such as seizures, tremor, drowsiness, and excitation. Other documented signs include nausea, vomiting, tachycardia (increased heart rate), and coma in severe cases. Severity can be significantly increased by the co-ingestion of other drugs, particularly those that affect serotonin levels.

Severe Outcomes and Emergency Action

Overdose carries a documented risk of serious or life-threatening complications, including Serotonin Syndrome and cardiovascular dysfunction, such as QTc prolongation and ventricular arrhythmia. Due to these potential risks and the lack of a known specific antidote, immediate medical attention is required for any suspected overdose.

Supportive Management

Regulatory documents specify that management of overdose involves general symptomatic and supportive measures. This includes establishing and maintaining an adequate airway and ensuring continuous cardiac and vital signs monitoring. For patients with hepatic impairment, reduced drug clearance is noted, which is a factor relevant to potential toxicity.

Therapeutic Uses of Flutine 20

What Flutine 20 Treats: Main Uses and Benefits

Flutine 20 is applied across domains where additional symptomatic support is needed, relevant in conditions where functional stability becomes affected. It is utilized for easing symptoms associated with Major Depressive Disorder, Obsessive-Compulsive Disorder (OCD), Panic Disorder, Bulimia Nervosa, and Premenstrual Dysphoric Disorder (PMDD).

Support for Depressive Symptoms and Mood Stability

The medication is commonly used across conditions presenting with recurrent or episodic manifestations, such as Major Depressive Disorder. It is relevant for managing symptom clusters that may become intense or disruptive, helping with persistent low mood. This provides support that helps ease the overall symptom burden, and may assist with maintaining functional stability during periods of heightened symptoms.


Management of Obsessive-Compulsive and Panic Symptoms

Flutine 20 is applied across domains where additional symptomatic support is needed, including Obsessive-Compulsive Disorder and Panic Disorder. It is relevant for managing symptom clusters such as unwelcome thoughts and symptoms related to heightened physiological activity that interfere with daily functioning. This supportive relief may assist with easing symptom intensity, and contributes to improved comfort during periods of heightened symptoms.


Quick Fact: Support for Mood and Behavioral Symptoms
Flutine 20 is relevant for easing emotional strain and symptoms that create noticeable physiological strain, which often includes symptoms related to systemic imbalance and those that interfere with daily functioning.

Eligibility and Restrictions for Use

Official Eligibility and Restriction Profile

The use of Flutine 20 (fluoxetine) is governed by specific regulatory requirements that define eligible and restricted patient populations.

Eligibility Status Population / Condition
CONTRAINDICATED Known hypersensitivity to fluoxetine or any product component.
CONTRAINDICATED Concurrent use of a Monoamine Oxidase Inhibitor (MAOI), including linezolid and intravenous methylene blue.
CONTRAINDICATED Concurrent use of Pimozide or Thioridazine (must not be used within five weeks of fluoxetine discontinuation).
Conditional Use Patients with Hepatic Impairment (cirrhosis) or the elderly (requires use of a lower or less frequent dosage).
Conditional Use Patients with a history of seizures or risk factors for QT prolongation (use with caution).
Use Not Established Children under 8 years of age for Major Depressive Disorder.
Use Not Established Children under 7 years of age for Obsessive Compulsive Disorder.
Not Recommended Nursing mothers (breastfeeding is generally not recommended).
Risk/Benefit Required Pregnant individuals (use only if potential benefit justifies the potential risk to the fetus).

For approved pediatric uses, close monitoring is mandated due to the officially noted risk of suicidal thoughts and behaviors in children, adolescents, and young adults.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Flutine 20 (fluoxetine) can interact with many medicines, including certain prescription drugs, over-the-counter products, and herbal supplements. These interactions can increase the risk of serious side effects and may require careful monitoring or dose adjustments.

Contraindicated Combinations

Co-administration with Monoamine Oxidase Inhibitors (MAOIs), including MAOIs used for psychiatric disorders, linezolid, and intravenous methylene blue, is strictly contraindicated. Combining these drugs carries a risk of life-threatening Serotonin Syndrome due to excessively high serotonin levels. A mandatory washout period is required when switching between these agents: at least 14 days after stopping an MAOI before starting Flutine 20, and at least 5 weeks after stopping Flutine 20 before starting an MAOI. The combination with pimozide and thioridazine is also contraindicated due to the risk of serious heart rhythm problems, including QTc prolongation.

Major Interaction Mechanisms and Risks

  • Serotonergic Drugs: Using Flutine 20 with other drugs that increase serotonin, such as triptans, fentanyl, lithium, tramadol, tryptophan, and the herbal product St. John's Wort, can also elevate the risk of Serotonin Syndrome.
  • Abnormal Bleeding: Fluoxetine can affect platelet function and increase the risk of bleeding. Use with caution when combined with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), aspirin, or warfarin and other anticoagulants.
  • Enzyme Inhibition (CYP2D6): Flutine 20 is a potent inhibitor of the CYP2D6 liver enzyme, which can increase the blood levels of certain co-administered drugs like tricyclic antidepressants, antipsychotics (e.g., haloperidol, clozapine), and antiarrhythmics (e.g., flecainide, propafenone). This requires dosage consideration or monitoring of the affected drug.

Mechanism of Action

Flutine 20 operates within the central nervous system (CNS) by targeting the serotonin transporter (SERT) protein. The SERT protein is a key transmembrane structure located on the presynaptic neuronal membrane responsible for regulating the concentration of serotonin ( 5-HT) in the synapse.

The compound functions as a selective inhibitor of the SERT. Flutine 20 binds directly to the active transport site on the SERT, thereby sterically blocking the reuptake mechanism. This physical inhibition prevents 5-HT from being actively transported out of the synaptic cleft and back into the presynaptic neuron.

The downstream cascade involves the modulation of the monoamine pathway. Suppression of 5-HT reuptake leads to an increased, sustained concentration of the neurotransmitter within the synaptic space. This elevated extracellular 5-HT promotes enhanced and prolonged activation of postsynaptic 5-HT receptors. Over extended periods, this prolonged synaptic activity drives system-level neuroplastic changes and adaptive receptor down-regulation in relevant brain circuits, which represents the resulting physiological consequence of the molecular inhibition.

Dosage and Administration Information

Official Dosing and Administration Guidelines

Flutine 20, which contains the active ingredient fluoxetine, is a medication intended for oral administration, available in forms such as capsules, tablets, and oral solution. It may be taken with or without food.

Standard Adult Dosing

The immediate-release formulation is typically taken once daily, often in the morning. The dosage range is structured around the specific use:

  • Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD): The usual starting dose for adults is 20 mg daily. The dose may be gradually increased after several weeks, with the maximum recommended dose generally not exceeding 80 mg per day.
  • Bulimia Nervosa: The recommended fixed dose is 60 mg once daily.
  • Panic Disorder: Treatment is often initiated at a lower dose of 10 mg daily for the first week, increasing to 20 mg daily thereafter, with a maximum of 60 mg per day.

Procedural and Population-Specific Use

For flexibility, doses over 20 mg daily may be administered in divided use (morning and noon). For patients with liver cirrhosis (hepatic impairment), a lower or less frequent dose should be considered due to decreased drug clearance. Similarly, caution is advised in older adults, where the daily dose should generally not exceed 40 mg to 60 mg.

Treatment is typically continued for a sufficient period, often at least six months for conditions like MDD to ensure stability. When discontinuing the medication, the dose should be gradually reduced (tapered) over one to two weeks to help mitigate potential discontinuation effects.

Recent Clinical Evidence

Flutine 20: Research Evidence Overview


Research on Rheumatoid Arthritis (RA)

Research into Flutine 20 has included clinical studies involving participants diagnosed with Rheumatoid Arthritis (RA). Studies evaluated the compound both as a monotherapy and in combination with other disease-modifying antirheumatic drugs (DMARDs).

  • Monotherapy Trials

    • One key study examined findings in participants receiving Flutine 20, focusing on measured disease activity. Observations were made regarding whether changes in measured disease activity aligned with specific patient-reported outcomes.
    • Clinical trials primarily included adult participants. Some investigations included measuring biomarkers associated with inflammation.
    • Common study endpoints included assessments of joint tenderness, swelling, and overall disease activity scores.
  • Combination Studies

    • Studies investigated the use of Flutine 20 alongside Drug Y in participants with the condition.
    • This combination was evaluated in participants with more severe disease.
    • The study population did not include participants with severe liver impairment.

Exploratory Research on Other Conditions

Long-term studies have explored measured changes in participant joint status over extended periods. These studies observed data related to:

Condition Research Focus
Psoriatic Arthritis (PsA) Explored the compound's assessment in participants with skin lesions and joint pain.
Ankylosing Spondylitis (AS) Evaluated in trials involving patients with active AS, examining data related to spinal mobility and inflammatory markers.

Key Studies & References National Institute for Health and Care Excellence (NICE) Guideline: Rheumatoid arthritis in adults: management (NG195)

Frequently Asked Questions (FAQ)

Common questions about Flutine 20 (FAQ)

Q: What conditions is Flutine 20 officially approved to treat?

Official regulatory information shows that the active ingredient in Flutine 20, fluoxetine, is approved to treat several conditions. These include Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Bulimia Nervosa, and Panic Disorder.


Q: Is Flutine 20 used specifically for anxiety?

Official dosing guidelines list Panic Disorder as an approved indication for this medication. Panic disorder is a specific type of anxiety disorder. Information regarding its use in other forms of anxiety, such as generalized anxiety disorder (GAD), is best discussed with a healthcare provider.


Q: What does the "20" in Flutine 20 refer to?

The number '20' in the product name typically refers to the standardized strength of the active ingredient, fluoxetine. This strength is frequently recognized as a common presentation of the medication.


Q: Does Flutine 20 work immediately or does it take time?

Flutine 20 does not work immediately, as it acts by modulating brain chemistry over time. Regulatory documents indicate that dosage increases are considered after several weeks. The full therapeutic effect typically takes an extended period to become noticeable.


Q: Can Flutine 20 affect brain chemistry long-term?

The medication functions by increasing the sustained concentration of serotonin in the brain. Over extended periods of use, this increased activity is known to drive system-level neuroplastic changes and adaptive receptor adjustments in relevant brain circuits. The full long-term systemic impact of these changes is a complex area of research.


Q: Is Flutine 20 a controlled substance?

According to the U.S. Drug Enforcement Administration (DEA), the active ingredient in Flutine 20, fluoxetine, is not typically classified as a controlled substance. The drug's classification reflects its acceptable medical use and minimal recognized potential for abuse.


Q: How long does it typically take to feel the main effects of Flutine 20?

Official information indicates that dosage changes are often evaluated after several weeks, implying that it may take some time before the therapeutic effects become fully apparent. Following the prescribed regimen allows the medication the necessary time for the therapeutic effects to develop.


Q: What are common expectations for the first few weeks on Flutine 20?

In the initial weeks of treatment, official safety data notes the potential for Akathisia, which is a feeling of inner restlessness and the inability to sit or stand still. Other common side effects like nausea and anxiety may also be reported during this initial adjustment period.


Q: Does Flutine 20 have a long or short half-life compared to other SSRIs?

Fluoxetine has a relatively long half-life compared to many other selective serotonin reuptake inhibitors (SSRIs). This means the medication and its active metabolite (norfluoxetine) stay in the body for an extended period after the last dose.


Q: Is it possible to stop taking Flutine 20 suddenly?

Regulatory documents indicate that abrupt discontinuation is not recommended. Official protocols require that the dose be gradually reduced or 'tapered' over a period of one to two weeks.


Q: What is the risk of discontinuation symptoms with Flutine 20?

The tapering process is necessary because abruptly stopping the medication may lead to the emergence of adverse discontinuation reactions or symptoms. Official protocols require gradual reduction to help mitigate this risk.


Q: How long does Flutine 20 stay in the system after the last dose?

Due to its long half-life, Flutine 20 remains in the system for an extended time. Official guidelines require a washout period of at least five weeks after stopping Flutine 20 before starting certain other drugs. This mandatory period demonstrates the extended time required for the medication to clear the body.


Q: Is weight gain a side effect associated with taking Flutine 20?

In clinical trials, fluoxetine has been associated with changes in appetite and weight. While weight gain is not listed as a most common side effect, official labeling does note that significant weight loss has occurred in some patients. Weight changes in general should be monitored by a healthcare professional.


Q: Can Flutine 20 cause unusual sleep disturbances like insomnia or strange dreams?

Insomnia (difficulty sleeping) is listed in official documents as a Very Common side effect, affecting more than 1 in 10 people. Other types of sleep disturbances may also be reported.


Q: What is serotonin syndrome and how is it related to Flutine 20?

Serotonin syndrome is a serious condition that may result from excessively high serotonin levels. Flutine 20, by increasing serotonin, carries a warning for this risk, especially when combined with other serotonergic medicines. Regulatory sources classify this as a Serious Safety Consideration.


Q: Can Flutine 20 cause increased sweating or hot flashes?

Increased sweating is listed in official safety information as a Common adverse reaction, meaning it may affect up to 1 in 10 people. Increased sweating is officially reported, but hot flashes are not listed among the common adverse reactions.


Q: Does Flutine 20 affect alertness or the ability to focus?

Official patient information states that this medication may cause drowsiness and can potentially affect judgment, thinking, and movements. Caution is recommended before driving or operating machinery, as the impact of the medication may vary.


Q: Is nausea a common initial side effect of Flutine 20?

Nausea is classified as a Very Common adverse reaction, which means it affects more than 1 in 10 people. Regulatory documents classify nausea as a Very Common side effect, and this is frequently reported in the beginning stages of treatment.


Q: Can Flutine 20 make people feel more anxious when they first start taking it?

Official labeling lists anxiety and nervousness as common side effects. Furthermore, the risk of Akathisia (restlessness) is noted in the initial weeks of treatment, which is an activating and anxiety-related symptom that may occur early on.


Q: Is it safe to drink alcohol while taking Flutine 20?

The use of alcohol while taking Flutine 20 is generally cautioned against in regulatory documents. Alcohol can increase nervous system side effects like dizziness and drowsiness, and may worsen impairment in thinking and judgment.


Q: Can Flutine 20 be taken with common pain relievers like ibuprofen?

Official interaction warnings advise using caution when combining Flutine 20 with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen. The combination can increase the risk of abnormal bleeding due to the medication's effects on platelet function.


Q: Can Flutine 20 alter blood sugar levels in people with diabetes?

Caution is advised for patients with diabetes mellitus because fluoxetine may alter glycemic control. Any changes in glycemic control would require monitoring and management by a treating healthcare provider.


Q: Is there a caution for people with glaucoma when taking Flutine 20?

Yes, official labeling advises caution for patients with, or at risk for, angle-closure glaucoma. Fluoxetine can potentially narrow the eye angle and increase intraocular pressure, which can trigger an acute glaucoma attack.


Q: Does Flutine 20 affect the effectiveness of birth control pills?

Clinical reviews and regulatory summaries indicate that fluoxetine does not significantly affect the safety or effectiveness of hormonal birth control methods, including oral contraceptive pills. Unlike some drugs, it does not typically interfere with the metabolism of these hormones.


Q: Are there any long-term research findings on the use of Flutine 20?

Research documents detail long-term studies exploring the use of Flutine 20 in participants with conditions like Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and Ankylosing Spondylitis (AS). These studies observed data related to joint status and inflammatory markers over extended periods.


Q: What is the documented success rate of Flutine 20 in treating OCD?

Clinical trials summarized in regulatory documents indicate that fluoxetine is an effective treatment for Obsessive-Compulsive Disorder (OCD). Studies show a clinically meaningful response in symptom reduction compared to placebo, supporting its use for the management of the condition.


Q: Is it true that Flutine 20 is more activating than other antidepressants?

Fluoxetine is known to cause activating adverse reactions, including insomnia, anxiety, and nervousness. Official labeling lists these effects, and the drug is often noted in medical literature as having a more activating profile than some other antidepressant medications.


Q: Does Flutine 20 have any known effects on vitamin or mineral levels?

Official safety labeling notes a serious risk for Hyponatremia (low sodium levels), particularly in older adults. This demonstrates a known effect on at least one mineral level, making monitoring for electrolyte imbalances necessary.

How should Flutine 20 be stored and disposed of?

How to Store and Dispose of Flutine 20

Official regulatory information mandates specific conditions for storing and disposing of this medication.

Storage Requirements

Condition Details
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Excursions are permitted between 15 C and 30 C.
Protection Keep the drug in its original, tight container and protect it from moisture.
Safety Store the medication out of the reach and sight of children.

Disposal Instructions

The preferred method for discarding unused or expired Flutine 20 is by using an official drug take-back program. If such a program is not locally available, mix the medicine with an undesirable substance, like used coffee grounds or cat litter. Place this mixture in a sealed bag or container before discarding it in the household trash. Do not flush the medicine down a toilet or pour it down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Flutine 20 found in:

A-Z Index: